The results revealed that highly enriched cDC, NKT, CD8+ T-cells, CD8+ Tcm, CD4+ Tem cells led to better overall survival in breast cancer, while the immunescore and other immune cell types enrichment scores didn’t show prognosis significance (Fig. 6a). This evidence concerns the gene CD8A and breast cancer.